Specificity of treatment response to infliximab in patients with inflammatory bowel disease and ankylosing spondylitis
P. 64-70
Authors:
T.Yu. Nuriakhmetova I.Kh. Valeeva Ya.O. Shevnina A.V. Petrov A.Kh. Odintsova R.Z. Abdrakipov T.B. Sibgatullin A.G. Vasil’ev D.I. Abdulganieva